UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048033
Receipt number R000054584
Scientific Title A prospective observational study of anesthetic concentration in umbilical cord blood and neonatal health status under epidural analgesia for labor.
Date of disclosure of the study information 2022/06/15
Last modified on 2025/07/27 16:15:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study of anesthetic concentration in umbilical cord blood and neonatal health status under epidural analgesia for labor.

Acronym

A prospective observational study of anesthetic concentration in umbilical cord blood and neonatal health status under epidural analgesia for labor.

Scientific Title

A prospective observational study of anesthetic concentration in umbilical cord blood and neonatal health status under epidural analgesia for labor.

Scientific Title:Acronym

A prospective observational study of anesthetic concentration in umbilical cord blood and neonatal health status under epidural analgesia for labor.

Region

Japan


Condition

Condition

Mother and her baby born under labor analgesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We measure umbilical cord blood anesthetic concentration under labor analgesia with ropivacaine and fentanyl. We study the relationship between umbilical cord blood anesthetic concentration and neonatal health status.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The relationship between umbilical cord blood anesthetic concentration and neonatal health status.

Key secondary outcomes

The relationship between umbilical cord blood anesthetic concentration and drug administration during labor analgesia.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

Pregnant women planning to undergo labor analgesia.
Patients with singleton pregnancy.
Patients whose delivery is between 37 and 42 weeks gestation.
Patients who can communicate in Japanese.

Key exclusion criteria

Patients with multiple pregnancies.
Patients with intrauterine fetal growth restriction.
Patients with pregnancy complication.
Patients with congenital anomalies in the fetus.

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Arisa
Middle name
Last name Ijuin

Organization

National center for child health and development

Division name

Department of clitical care and anesthesia

Zip code

157-8535

Address

2-10-1 Okura, Setagaya-ku, Tokyo

TEL

03-3416--0181

Email

ijyuin-a@ncchd.go.jp


Public contact

Name of contact person

1st name Arisa
Middle name
Last name Ijuin

Organization

National center for child health and development

Division name

Department of clitical care and anesthesia

Zip code

157-8535

Address

2-10-1 Okura, Setagaya-ku, Tokyo

TEL

03-3416-0181

Homepage URL


Email

ijyuin-a@ncchd.go.jp


Sponsor or person

Institute

National center for child health and development

Institute

Department

Personal name



Funding Source

Organization

National center for child health and development

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National center for child health and development

Address

2-10-1 Okura, Setagaya-ku, Tokyo

Tel

03-3416-0181

Email

rinri@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 15 Day


Related information

URL releasing protocol

https://link.springer.com/article/10.1007/s12630-025-02975-7

Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s12630-025-02975-7

Number of participants that the trial has enrolled

50

Results

The ropivacaine and fentanyl concentrations were 77 [56-98] ng/mL and 0.125 [0.125-0.20] ng/mL at delivery, respectively. The umbilical analgesic concentrations were correlated with the labour duration and total dose.The umbilical arterial pH was over 7.2 and the Apgar score at 5 min was above 8 for all neonates. No neonates exhibited systemic local anesthetic toxicity. Respiratory support was required for 14 neonates.

Results date posted

2025 Year 07 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2025 Year 06 Month 10 Day

Baseline Characteristics

A pregnant woman who gave birth with labor analgesia at the National Center for Child Health and Development, and her baby.

Participant flow

We consecutively recruited all pregnant people who requested labour analgesia at the National Center for Child Health and Development (Tokyo, Japan) between July and September 2022 for this prospective observational study. We obtained written informed consent from all participants.

Adverse events

None

Outcome measures

umbilical venous analgesic concentrations and neonatal characteristics.

Plan to share IPD

None

IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2022 Year 06 Month 10 Day

Date of IRB

2022 Year 06 Month 03 Day

Anticipated trial start date

2022 Year 07 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We measure umbilical cord blood anesthetic concentration under epidural labor analgesia.
We investigate the relationship between umbilical cord blood anesthetic concentration and neonatal health status.
We examine the relationship between drug adminstration and umbilical cord blood anesthetic concentration.


Management information

Registered date

2022 Year 06 Month 11 Day

Last modified on

2025 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054584